Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Buy Us a Coffee
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2025-10228
Vulnerability Information
Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
Session Hijacking in Rolantis Information Technologies' Agentis
Source: NVD (National Vulnerability Database)
Vulnerability Description
Session Fixation vulnerability in Rolantis Information Technologies Agentis allows Session Hijacking.This issue affects Agentis: before 4.44.
Source: NVD (National Vulnerability Database)
CVSS Information
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
Source: NVD (National Vulnerability Database)
Vulnerability Type
会话固定
Source: NVD (National Vulnerability Database)
Vulnerability Title
Rolantis Agentis 授权问题漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Rolantis Agentis是土耳其Rolantis公司的一个用于企业信息管理和自动化处理的软件。 Rolantis Agentis 4.44之前版本存在授权问题漏洞，该漏洞源于会话固定问题，可能导致会话劫持。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
Rolantis Information TechnologiesAgentis 0 ~ 4.44 -
II. Public POCs for CVE-2025-10228
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2025-10228
Please Login to view more intelligence information
IV. Related Vulnerabilities
Same product: Agentis
Same vendor: Rolantis Information Technologies
Same weakness: CWE-384
V. Comments for CVE-2025-10228

No comments yet

Leave a comment